- Home
- STVN
as of 03-10-2026 3:54pm EST
$15.02
$0.56
-3.63%
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
| Founded: | 1949 | Country: | Italy |
| Employees: | N/A | City: | N/A |
| Market Cap: | 4.2B | IPO Year: | 2021 |
| Target Price: | $25.13 | AVG Volume (30 days): | 636.8K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $13.91 - $28.00 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 10.26% | Revenue Growth (next year): | 10.02% |
| P/E Ratio: | 27.15 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Latest Stevanato Group S.p.A. News
STVN Breaking Stock News: Dive into STVN Ticker-Specific Updates for Smart Investing
Compare STVN vs Leading Stocks
See how STVN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "STVN Stevanato Group S.p.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.